Skip to main content
. 2020 May 12;20:220. doi: 10.1186/s12888-020-02632-x

Table 1.

Sample characteristics

Variable Total Male (n = 192) Female (n = 130) p value
Age years mean (95% CI) 47.8 (46–49.5) 49 (47–51) 46 (43–49) 0.12
Education <6th grade n (%) 301 (93) 182 (94) 119 (92) 0.13
Married n (%) 288 (89) 169 (88) 49 (89) 0.31
Have young children < 18 yrs. n (%) 79 (25) 43 (22) 36 (28) 0.28
Employed n (%) 125 (39) 97 (51) 28 (22) 0.00
Substance Abuse n (%) 108 (34) 75 (39) 33 (25) 0.01
Experienced Life Stressors n (%) 6 (2) 2 (1.0) 4 (3) 0.18
Low Social Support n (%) 62 (19) 39 (20) 23 (18) 0.65
Indication for ICU stay n (%) 0.58
 Postoperative 117 (36)
 Medical 101 (32)
 Neurological 68 (21)
 Trauma 36 (11)
Length of Stay in ICU days mean (95% CI) 4.7 (4.2–5.1) 4.7 (4.1–5.2) 4.6 (4.0–5.2) 0.68
APACHE II mean (95% CI) 9.5 (9–10) 9.7 (9.0–10.4) 9.2 (8.4–9.9) 0.23
SOFA score mean (95% CI) 3.4 (3–3.7) 3.3 (2.9–3.7) 3.4 (2.8–4.0) 0.85
Mechanical Ventilation > 48 h n (%) 169 (53) 105 (54.7) 64 (50) 0.34
RAS scores mean (95% CI) −0.4(− 0.3to-0.5) −0.38 (− 0.24 to − 0.5) −0.47 (− 0.33 to − 0.61) 0.38
Administered benzodiazepine n (%) 163 (51) 99 (51.6) 64 (49) 0.68
Administered Steroids n (%) 145 (45) 84 (44) 61 (47) 0.57
IESr in ICU median (IQR) 7 (6) 8(5) 7 (6) 0.16
IESr at 1-month median (IQR) 2 (2) 2 (2) 2 (3) 0.88
IESr at 3 months median (IQR) 0 (2) 0 (2) 0 (2) 0.87
HADS in ICU median (IQR) 10 (5) 10 (4) 8 (4) 0.71
HADS at 1-month median (IQR) 3 (2) 3 (2) 3 (3) 0.95
HADS at 3 months median (IQR) 2 (3) 3(3) 2 (4) 0.58
EQ5D VAS in ICU 35 (10) 35 (10) 35 (10) 0.3
EQ5D VAS 30 d 70 (15) 70 (11) 70 (15) 0.34
EQ5D VAS 90 d 80 (11) 80 (15) 80 (10) 0.69

APACHE Acute Physiology and Chronic Health Evaluation score, SOFA Sequential Organ Failure Assessment, RAS Richmond Agitation Sedation Scale, IES-r Impact of Events Scale-Revised, HADS Hospital Anxiety Depression Scale, IQR Inter Quartile Range, EQ5D VAS Visual Analogue Score in European Quality of Life 5 dimensions tool, d days